<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">

  <title>NICE Formulary - LEVOBUPIVACAINE</title>

  <meta name="X-UA-Compatible" content="IE=edge,chrome=1">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0">
  <meta name="description" content="">
  <meta name="author" content="NICE - The National Institute of Health and Care Excellence">

  <!--[if lt IE 9]>
  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/html5shiv.js"></script>
  <![endif]-->

  <!-- Le styles -->
  <link rel="stylesheet" href="http://mattonfoot.github.io/NICE.UI/styles/ui.css">

  <!-- Fav and touch icons -->
  <link rel="shortcut icon" href="http://cdn.nice.org.uk/V3/Content/nice/favicon.ico">
  <link rel="apple-touch-icon-precomposed" href="http://cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
  <meta name="msapplication-TileColor" content="#fafafb">
  <meta name="msapplication-TileImage" content="http://cdn.nice.org.uk/V3/Content/nice/favicon-144.png">

  <style>
  .tab-content {
    overflow: auto;
  }
  .tab-content > .tab-pane {
    display: none;
  }
  .tab-content > .active {
    display: block;
  }

  header .nav {
    list-style: decimal inside none;
  }
  header .nav > li {
    display: list-item;
  }
  header .nav > li > a {
    display: block;
    margin: 0;
    padding: 0;
    text-decoration: none;
    color: #01769d;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus,
  header .nav > li.active > a,
  header .nav > li.active > a:hover,
  header .nav > li.active > a:focus {
    outline: 0;
    color: #08455b;
    background: transparent;
    text-decoration: none;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus {
    text-decoration: underline;
  }

  [outputclass="title"],
  .title {
    font-size: 19px;
    font-size: 1.9rem;
    line-height: 24px;
    line-height: 2.4rem;
  }

  h3, h4, h5, h6, .title, [outputclass="title"] {
    margin-bottom: 0;
  }

  h1+p, h2+p, h3+p, h4+p, h5+p, h6+p, .title+p, [outputclass="title"]+p {
    margin-top: 0;
  }

  .doses {
    padding-left: 0;
    list-style: none;
  }
  .doses .dose {
    padding-left: 24px;
    padding-left: 2.4rem;
    margin-bottom: 6px;
    margin-bottom: .6rem;
  }
  .doses .adult {
    border-left: 7px solid #346e7f;
  }
  .doses .child {
    border-left: 7px solid #82176F;
  }

  /* DITA symbols */

  ph {
    color: #006;
  }

  tm::before {
    font-size: .8em;
    margin-left: -.2em;
    vertical-align: top;
  }
  tm[tmtype="reg"]::before {
    content: "\00ae";
  }
  tm[tmtype="copy"]::before {
    content: "\00a9";
  }
  tm[tmtype="trade"]::before {
    content: "\2122";
  }

  </style>
</head>

<body id="" class="">
  <header>
    <div class="container">
      <ul class="breadcrumb">
        <li><a href="../">Home</a> <span class="divider glyph-chevron-right"></span></li>
        <li class="active"><a href="../drug/">Drugs</a></li>
      </ul>

      <h1>LEVOBUPIVACAINE</h1>


      <nav>
        <ul class="nav nav-list">

          <li class="active"><a href="#indicationsAndDoses" data-toggle="tab">Indications and doses</a></li>
          <li><a href="#pregnancy" data-toggle="tab">Pregnancy</a></li>
          <li><a href="#hepaticImpairment" data-toggle="tab">Hepatic impairment</a></li>
          <li><a href="#contraindications" data-toggle="tab">Contra indications</a></li>
          <li><a href="#sideEffects" data-toggle="tab">Side effects</a></li>
          <li><a href="#directionsForAdministration" data-toggle="tab">Administration</a></li>
          <li><a href="#importantSafetyInformation" data-toggle="tab">Important safety information</a></li>
          <li><a href="#cautions" data-toggle="tab">Cautions</a></li>
          <li><a href="#prescribingAndDispensingInformation" data-toggle="tab">Prescribing and dispensing</a></li>
          <li><a href="#allergyAndCrossSensitivity" data-toggle="tab">Allergy and cross sensitivity</a></li>
          <li><a href="#medicinalForms" data-toggle="tab">Medicinal forms</a></li>
        </ul>
      </nav>

      <br/>
    </div>
  </header>

  <div class="container">
    <div class="tab-content">

      <section class="tab-pane active" id="indicationsAndDoses">
        <h2>Indications and doses</h2>

        <section class="indicationAndDoseGroups">
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Acute postoperative pain</span>,
            </h4>
            <p class="specificity"><span class="route">By continuous epidural infusion</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                12.5&#8211;18.75 mg/hour, dose administered using a 1.25 mg/mL (0.125%) or 2.5 mg/mL (0.25%) solution; maximum 400 mg per day.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Acute labour pain</span>,
            </h4>
            <p class="specificity"><span class="route">Initially by lumbar epidural</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                15&#8211;25 mg every 15 minutes as required, dose administered using a 2.5 mg/mL (0.25%) solution, alternatively (by continuous epidural infusion) 5&#8211;12.5 mg/hour, dose administered using a 1.25 mg/mL (0.125%) solution.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Surgical anaesthesia, peripheral nerve block</span>,
            </h4>
            <p class="specificity"><span class="route">By regional administration</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                2.5&#8211;150 mg, dose administered using a 2.5 mg/mL (0.25%) or 5 mg/mL (0.5%) solution.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Surgical anaesthesia, peribulbular nerve block</span>,
            </h4>
            <p class="specificity"><span class="route">By regional administration</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                37.5&#8211;112.5 mg, dose administered using a 7.5 mg/mL (0.75%) solution.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Surgical anaesthesia for caesarean section</span>,
            </h4>
            <p class="specificity"><span class="route">By lumbar epidural</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                75&#8211;150 mg, to be given over 15 &#8211;20 minutes, dose administered using a 5 mg/mL (0.5%) solution.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Surgical anaesthesia</span>,
            </h4>
            <p class="specificity"><span class="route">By local infiltration</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                50&#8211;150 mg, to be given over 5 minutes, dose administered using a 5 mg/mL (0.5%) or 7.5 mg/mL (0.75%) solution.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                15 mg, dose administered using a 5 mg/mL (0.5%) solution.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                2.5&#8211;150 mg, dose administered using a 2.5 mg/mL (0.25%) solution.</li>
            </ul>
          </section>
        </section>
        
        
        
            <section class="extremesOfBodyWeight">
                <h3>Doses at extremes of body-weight</h3>
              <p>To avoid excessive dosage in obese patients, dose may need to be calculated on the basis of ideal body- weight.</p>
            </section>
        
        
      </section>



      <section class="tab-pane" id="pregnancy">
        <h2>Advice when patient is pregnant</h2>

            <section class="generalInformation">
              <p>Large doses during delivery can cause neonatal respiratory depression, hypotonia, and bradycardia after epidural block.</p><p>Avoid if possible in the first trimester&#8212;toxicity in <i>animal</i> studies.</p><p>May cause fetal distress syndrome.</p><p>Do not use for paracervical block in obstetrics.</p><p>Do not use 7.5&#8239;mg/mL strength in obstetrics.</p>
            </section>
      </section>

      <section class="tab-pane" id="hepaticImpairment">
        <h2>Advice regarding hepatic impairment</h2>

            <section class="generalInformation">
              <p>Use with caution.</p>
            </section>
      </section>


      <section class="tab-pane" id="contraindications">
        <h2>Contra indications</h2>

          <ul>
            <li>Application to the middle ear (can cause ototoxicity)</li>
            <li>avoid injection into infected tissues</li>
            <li>avoid injection into inflamed tissues</li>
            <li>complete heart block</li>
            <li>preparations containing preservatives should not be used for caudal, epidural, or spinal block, or for intravenous regional anaesthesia (Bier&#8217;s block)</li>
            <li>should not be applied to damaged skin</li>
          </ul>
      </section>

      <section class="tab-pane" id="sideEffects">
        <h2>Known side effects</h2>

          <h3>General side effects</h3>
              <p>
                <strong>notKnown:</strong> Anaemia, arrhythmias, blurred vision, cardiac arrest, convulsions, dizziness, drowsiness, feeling of inebriation, headache, lightheadedness, muscle twitching, myocardial depression (resulting in hypotension and bradycardia), nausea, numbness of the tongue and perioral region, paraesthesia (including sensations of hot and cold), peripheral vasodilatation (resulting in hypotension and bradycardia), pyrexia, restlessness, sweating, tinnitus, transient excitation (followed by depression with drowsiness, respiratory failure, unconsciousness, and coma), tremors, vomiting,
              </p>
        
        
            <section class="advice">
                <h3>Toxic effects</h3>
              <p>Toxic effects after administration of local anaesthetics are a result of excessively high plasma concentrations; severe toxicity usually results from inadvertent intravascular injection or too rapid injection.</p><p>Following most regional anaesthetic procedures, maximum arterial plasma concentration of anaesthetic develops within about 10 to 25 minutes, so careful surveillance for toxic effects is necessary during the first 30 minutes after injection.</p><p>The systemic toxicity of local anaesthetics mainly involves the central nervous and cardiovascular systems.</p>
            </section>
        
      </section>

      <section class="tab-pane" id="directionsForAdministration">
        <h2>Directions for administration</h2>

            <section class="directionsForAdministration">
              <p>For 1.25&#8239;mg/mL concentration dilute standard solutions with sodium chloride 0.9%.</p>
            </section>
      </section>



      <section class="tab-pane" id="importantSafetyInformation">
        <h2>Important safety information</h2>

            <section class="importantSafetyInformation">
              <p>The licensed doses stated may not be appropriate in some settings and expert advice should be sought.</p><p>Should only be administered by, or under the direct supervision of, personnel experienced in their use, with adequate training in anaesthesia and airway management, and should not be administered parenterally unless adequate resuscitation equipment is available.</p>
            </section>
      </section>

      <section class="tab-pane" id="cautions">
        <h2>Cautions regarding administration</h2>

        <ul>
          <li>
            Cardiovascular disease
          </li>
          <li>
            debilitated patients (consider dose reduction)
          </li>
          <li>
            elderly (consider dose reduction)
          </li>
          <li>
            epilepsy
          </li>
          <li>
            hypovolaemia
          </li>
          <li>
            impaired cardiac conduction
          </li>
          <li>
            impaired respiratory function
          </li>
          <li>
            myasthenia gravis
          </li>
          <li>
            shock
          </li>
        </ul>
      </section>




      <section class="tab-pane" id="prescribingAndDispensingInformation">
        <h2>Information regarding prescribing and dispensing</h2>

            <section class="prescribingAndDispensingInformation">
              <p>Levobupivacaine is an isomer of bupivacaine.</p>
            </section>
      </section>








      <section class="tab-pane" id="allergyAndCrossSensitivity">
        <h2>Advice regarding allergies and cross sensitivities</h2>

        
            <section class="crossSensitivity">
                <h3>Hypersensitivity and cross-sensitivity</h3>
              <p>Hypersensitivity reactions occur mainly with the ester-type local anaesthetics, such as tetracaine and chloroprocaine; reactions are less frequent with the amide types, such as articaine, bupivacaine, levobupivacaine, lidocaine, mepivacaine, prilocaine, and ropivacaine. Cross-sensitivity reactions may be avoided by using the alternative chemical type.</p>
            </section>
      </section>

      <section class="tab-pane" id="medicinalForms">
        <h2>Prepared medicinal forms of LEVOBUPIVACAINE</h2>


            <section class="licensingVariationStatement">
              <p>There can be variation in the licensing of different medicines containing the same drug.</p>
            </section>
        

            <div id="PHP75739"><a href="../medicinalForm/PHP75739.html" data-target="#PHP75739" data-action="load">Solution for injection</a></div>
            <div id="PHP75750"><a href="../medicinalForm/PHP75750.html" data-target="#PHP75750" data-action="load">Infusion</a></div>
      </section>
    </div>
  </div>

  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/jquery.js"></script>
  <script src="http://cdn.nice.org.uk/V3/Scripts/twitter.bootstrap.js"></script>
  <script src="/content/scripts/NICE.RemoteLoad.js"></script>
</html>
